4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-20-012481
CIK 0000810509other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:18 PM ET
Size
4.4 KB
Accession
0001437749-20-012481
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2020-06-02$2.62/sh+6,847$17,939→ 13,097 total
Footnotes (1)
- [F1]Stock granted under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:18 PM ET
- Size
- 4.4 KB